Research work · 2013
Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial
Luana Calabrò, Aldo Morra, Ester Fonsatti, Ornella Cutaia, Giovanni Amato, Diana Giannarelli, Anna Maria Di Giacomo, Riccardo Danielli, Maresa Altomonte, Luciano Mutti, Michele Maio
The Lancet Oncology